Mark Shapiro

2.0k total citations
49 papers, 1.4k citations indexed

About

Mark Shapiro is a scholar working on Oncology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark Shapiro has authored 49 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 18 papers in Hematology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark Shapiro's work include Chronic Myeloid Leukemia Treatments (16 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Mark Shapiro is often cited by papers focused on Chronic Myeloid Leukemia Treatments (16 papers), Chronic Lymphocytic Leukemia Research (15 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Mark Shapiro collaborates with scholars based in United States, Italy and Germany. Mark Shapiro's co-authors include Juan P. Wisnivesky, Cynthia Chin, Todd S. Weiser, Steven Swanson, Jörge E. Cortes, Cameron D. Wright, Robert J. Korst, Shubin Sheng, Carlo Gambacorti‐Passerini and Hagop M. Kantarjian and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Mark Shapiro

46 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Shapiro United States	21	537	471	351	317	210	49	1.4k
B. Audhuy France	20	316 0.6×	986 2.1×	432 1.2×	375 1.2×	88 0.4×	48	1.9k
P. Berthaud France	14	498 0.9×	409 0.9×	465 1.3×	311 1.0×	71 0.3×	42	1.3k
Christian Taverna Switzerland	17	397 0.7×	420 0.9×	175 0.5×	146 0.5×	350 1.7×	47	1.2k
Jeffrey Margolis United States	18	227 0.4×	307 0.7×	524 1.5×	154 0.5×	124 0.6×	35	1.1k
Eefke Petersen Netherlands	21	124 0.2×	446 0.9×	924 2.6×	251 0.8×	173 0.8×	69	1.7k
Oliver Glidewell United States	24	542 1.0×	910 1.9×	281 0.8×	256 0.8×	62 0.3×	44	1.8k
Ho‐Jin Shin South Korea	22	234 0.4×	655 1.4×	944 2.7×	365 1.2×	233 1.1×	182	2.0k
C. Portlock United States	21	367 0.7×	732 1.6×	126 0.4×	438 1.4×	114 0.5×	36	1.6k
Mathias Hänel Germany	21	228 0.4×	675 1.4×	734 2.1×	484 1.5×	153 0.7×	72	1.8k
Gregory A. Threatte United States	12	374 0.7×	261 0.6×	208 0.6×	741 2.3×	60 0.3×	22	1.4k

Countries citing papers authored by Mark Shapiro

Since Specialization

Citations

This map shows the geographic impact of Mark Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Shapiro more than expected).

Fields of papers citing papers by Mark Shapiro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Shapiro. The network helps show where Mark Shapiro may publish in the future.

Co-authorship network of co-authors of Mark Shapiro

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Shapiro. A scholar is included among the top collaborators of Mark Shapiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Shapiro. Mark Shapiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Jiawei, et al.. (2025). Model‐Informed Drug Development Applications and Opportunities in mRNA ‐ LNP Therapeutics. Clinical Pharmacology & Therapeutics. 118(6). 1329–1339. 3 indexed citations

Rahib, Lola, Karen Chen, Allyson J. Ocean, et al.. (2020). Use of a real-world data approach to rapidly generate outcomes data following a case study of a novel treatment combination in pancreatic adenocarcinoma.. Journal of Clinical Oncology. 38(15_suppl). e16735–e16735. 3 indexed citations

Gambacorti‐Passerini, Carlo, Jörge E. Cortes, Jeff H. Lipton, et al.. (2018). Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase I/II study. Haematologica. 103(8). 1298–1307. 44 indexed citations

Shapiro, Mark, et al.. (2015). Nodal Upstaging in Robotic and Video Assisted Thoracic Surgery Lobectomy for Clinical N0 Lung Cancer. The Annals of Thoracic Surgery. 100(1). 229–234. 55 indexed citations

Brümmendorf, Tim H., Jörge E. Cortes, H. Jean Khoury, et al.. (2014). Bosutinib As Second-Line Therapy in Patients (Pts) with Chronic Phase Chronic Myeloid Leukemia (CP CML) Resistant or Intolerant to Prior Imatinib: 60-Month Update of a Phase 1/2 Study. Blood. 124(21). 5544–5544. 1 indexed citations

Shapiro, Mark, Gal Akiri, Cynthia Chin, et al.. (2012). Wnt Pathway Activation Predicts Increased Risk of Tumor Recurrence in Patients With Stage I Nonsmall Cell Lung Cancer. Annals of Surgery. 257(3). 548–554. 41 indexed citations

Shapiro, Mark, Grace Mhango, Max Kates, et al.. (2012). Extent of lymph node resection does not increase perioperative morbidity and mortality after surgery for stage I lung cancer in the elderly. European Journal of Surgical Oncology. 38(6). 516–522. 25 indexed citations

Maroto, Pablo, Gary R. Hudes, Janice P. Dutcher, et al.. (2011). Drug-Related Pneumonitis in Patients With Advanced Renal Cell Carcinoma Treated With Temsirolimus. Journal of Clinical Oncology. 29(13). 1750–1756. 83 indexed citations

Shapiro, Mark, Birte Wistinghausen, Peter S. Midulla, & Cynthia Chin. (2011). Metastatic osteosarcoma presenting as a singlepulmonary microembolus. Journal of Pediatric Surgery. 46(3). 574–576. 5 indexed citations

10.

Advani, Anjali S., Bertrand Coiffier, Myron S. Czuczman, et al.. (2010). Safety, Pharmacokinetics, and Preliminary Clinical Activity of Inotuzumab Ozogamicin, a Novel Immunoconjugate for the Treatment of B-Cell Non-Hodgkin's Lymphoma: Results of a Phase I Study. Journal of Clinical Oncology. 28(12). 2085–2093. 255 indexed citations

11.

Shapiro, Mark, Steven Swanson, Cameron D. Wright, et al.. (2010). Predictors of Major Morbidity and Mortality After Pneumonectomy Utilizing The Society for Thoracic Surgeons General Thoracic Surgery Database. The Annals of Thoracic Surgery. 90(3). 927–935. 152 indexed citations

12.

Shapiro, Mark, Claudia I. Vidal, Aaron M. Lipskar, Joan Gil, & Virginia R. Litle. (2009). Placental Transmogrification of the Lung Presenting as Emphysema and a Lung Mass. The Annals of Thoracic Surgery. 87(2). 615–616. 16 indexed citations

13.

Hernandez, Jonathan M., Sarah M. Cowgill, Sam Al-Saadi, et al.. (2008). An Aggressive Approach to Extrahepatic Cholangiocarcinomas Is Warranted: Margin Status Does Not Impact Survival after Resection. Annals of Surgical Oncology. 15(3). 807–814. 30 indexed citations

14.

Shapiro, Mark, Alexander J. Greenstein, John C. Byrn, et al.. (2008). Surgical Management and Outcomes of Patients with Duodenal Crohn's Disease. Journal of the American College of Surgeons. 207(1). 36–42. 25 indexed citations

15.

Lockhart, A. Craig, Ronald M. Bukowski, Mace L. Rothenberg, et al.. (2006). Phase I trial of oral MAC-321 in subjects with advanced malignant solid tumors. Cancer Chemotherapy and Pharmacology. 60(2). 203–209. 20 indexed citations

16.

Weinberger, Miriam, Ahmed Eid, Mark Shapiro, et al.. (1995). DisseminatedNocardia transvalensis infection resembling pulmonary infarction in a liver transplant recipient. European Journal of Clinical Microbiology & Infectious Diseases. 14(4). 337–341. 8 indexed citations

17.

Shapiro, Mark & Lawrence J. Brandt. (1994). Endoscopy in the age of HIV: A study of current practices and attitudes. Gastrointestinal Endoscopy. 40(4). 477–480. 6 indexed citations

18.

Shapiro, Mark, et al.. (1955). Malignant disease in the Transvaal. II. Tumours of the musculo-skeletal system. III. Cancer of the respiratory tract; first statistical report of the radiation therapy department of the Johannesburg group of hospitals.. PubMed. 29(5). 95–101. 5 indexed citations

19.

Shapiro, Mark, et al.. (1955). The Aetiology of Respiratory Tract Cancer in the South African Bantu. British Journal of Cancer. 9(4). 528–538. 16 indexed citations

20.

Cohen, Lorenzo, et al.. (1952). Malignant disease in the Transvaal. I. Cancer of the skin; first statistical report from the Radiation Therapy Department of the Johannesburg group of hospitals.. PubMed. 26(47). 932–9. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact